ArticleVaccines2024

Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.

Wanqi Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.